Status and challenges for tuberculosis control in India–Stakeholders' perspective
G Thakur, S Thakur, H Thakur - Indian Journal of Tuberculosis, 2021 - Elsevier
Background Tuberculosis is one of the ten major causes of mortality worldwide. The trend of
increasing TB cases and drug resistance in India is very disturbing. The objectives of the …
increasing TB cases and drug resistance in India is very disturbing. The objectives of the …
Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies
TA Jhaveri, D Jhaveri, A Galivanche… - PLoS …, 2024 - journals.plos.org
Background India accounts for about one-quarter of people contracting tuberculosis (TB)
disease annually and nearly one-third of TB deaths globally. Many Indians do not navigate …
disease annually and nearly one-third of TB deaths globally. Many Indians do not navigate …
[HTML][HTML] The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: a systematic review …
Objectives We aimed to evaluate the effect of undernutrition on sputum culture conversion
and treatment outcomes among people with multidrug-resistant tuberculosis (MDR-TB) …
and treatment outcomes among people with multidrug-resistant tuberculosis (MDR-TB) …
Undernutrition and treatment success in drug-resistant tuberculosis in Uganda
JB Baluku, S Namiiro, M Nabwana… - Infection and drug …, 2021 - Taylor & Francis
Background Undernutrition is associated with unfavourable treatment outcomes among
people with drug-resistant tuberculosis (DRTB). Factors influencing the treatment outcomes …
people with drug-resistant tuberculosis (DRTB). Factors influencing the treatment outcomes …
Development and validation of a prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance tuberculosis
JB Ma, LC Zeng, F Ren, LY Dang, H Luo, YQ Wu… - BMC Infectious …, 2023 - Springer
Abstract Background The World Health Organization has reported that the treatment success
rate of multi-drug resistance tuberculosis is approximately 57% globally. Although new …
rate of multi-drug resistance tuberculosis is approximately 57% globally. Although new …
Treatment Outcomes and Associated Influencing Factors Among Patients with Rifampicin-Resistant Tuberculosis: A Multicenter, Retrospective, Cohort Study in China
L Zou, W Kang, C Guo, J Du, Q Chen, Z Shi… - Infection and Drug …, 2024 - Taylor & Francis
Objective Rifampin-resistant tuberculosis (RR-TB) remains a serious global public health
concern. We assessed treatment outcomes and associated influencing factors among RR …
concern. We assessed treatment outcomes and associated influencing factors among RR …
Treatment outcome of MDR/RR TB in a resource-constrained setup: a four-year retrospective analysis
AA Omer, MD Meshesha, AT Ajema… - Infection and Drug …, 2022 - Taylor & Francis
Introduction The emergence of drug resistance in TB treatment is a major public health
threat. However, there are limited studies which are directed towards identifying factors that …
threat. However, there are limited studies which are directed towards identifying factors that …
[HTML][HTML] Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant …
S Soedarsono, NM Mertaniasih… - The International …, 2024 - journals.lww.com
Background: Bedaquiline is one of the core drugs used to treat multidrug-resistant TB (MDR-
TB). Delamanid is one of the companion drugs in group C which is used to complete the …
TB). Delamanid is one of the companion drugs in group C which is used to complete the …
Treatment outcomes of multidrug resistant tuberculosis (MDR TB) treated with bedaquiline under programmatic management of drug resistant tuberculosis at a tertiary …
S Kumari, A Gupta, V Chopra, S Kaur - Indian Journal of Tuberculosis, 2024 - Elsevier
Introduction MDR TB is a serious global concern which is hampering TB elimination goals
badly. Standardized MDR TB regimen had high default rates, more side effects and poor …
badly. Standardized MDR TB regimen had high default rates, more side effects and poor …
A Scoring System Based on Laboratory Parameters and Clinical Features to Predict Unfavorable Treatment Outcomes in Multidrug-and Rifampicin-Resistant …
J Yan, H Luo, Q Nie, S Hu, Q Yu… - Infection and Drug …, 2023 - Taylor & Francis
Background The growth of antibiotic resistance to Mycobacterium TB represents a major
barrier to the goal of “Ending the global TB epidemics”. This study aimed to develop and …
barrier to the goal of “Ending the global TB epidemics”. This study aimed to develop and …